- Home
- NTZ vs ONCY Comparison
NTZ vs ONCY Comparison
Compare NTZ & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- ONCY
- Stock Information
- Founded
- NTZ 1959
- ONCY 1998
- Country
- NTZ Italy
- ONCY Canada
- Employees
- NTZ N/A
- ONCY N/A
- Industry
- NTZ Home Furnishings
- ONCY Pharmaceuticals and Biotechnology
- Sector
- NTZ Consumer Discretionary
- ONCY Health Care
- Exchange
- NTZ Nasdaq
- ONCY Nasdaq
- Market Cap
- NTZ 52.2M
- ONCY 49.2M
- IPO Year
- NTZ 1993
- ONCY 1999
- Fundamental
- Price
- NTZ $3.95
- ONCY $0.57
- Analyst Decision
- NTZ
- ONCY Strong Buy
- Analyst Count
- NTZ 0
- ONCY 3
- Target Price
- NTZ N/A
- ONCY $4.33
- AVG Volume (30 Days)
- NTZ 7.8K
- ONCY 338.6K
- Earning Date
- NTZ 06-20-2025
- ONCY 05-08-2025
- Dividend Yield
- NTZ N/A
- ONCY N/A
- EPS Growth
- NTZ N/A
- ONCY N/A
- EPS
- NTZ N/A
- ONCY N/A
- Revenue
- NTZ $365,846,531.00
- ONCY N/A
- Revenue This Year
- NTZ N/A
- ONCY N/A
- Revenue Next Year
- NTZ N/A
- ONCY N/A
- P/E Ratio
- NTZ N/A
- ONCY N/A
- Revenue Growth
- NTZ N/A
- ONCY N/A
- 52 Week Low
- NTZ $3.80
- ONCY $0.47
- 52 Week High
- NTZ $6.43
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- NTZ 39.90
- ONCY 52.07
- Support Level
- NTZ $3.95
- ONCY $0.55
- Resistance Level
- NTZ $4.49
- ONCY $0.65
- Average True Range (ATR)
- NTZ 0.49
- ONCY 0.05
- MACD
- NTZ -0.03
- ONCY 0.01
- Stochastic Oscillator
- NTZ 9.15
- ONCY 71.28
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.